You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus

Article metrics

Article menu

Download PDFPDF

Biomarker studies
Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus

 

Online download statistics by month:

Online download statistics by month: September 2016 to March 2024

AbstractFullPdf
Sep 2016462515
Oct 201632183226
Nov 20161295636
Dec 2016891914
Jan 20171002515
Feb 201701816
Mar 201702614
Apr 20170489
May 201724016
Jun 2017103118
Jul 201736366
Aug 201744447
Sep 201747477
Oct 201739384
Nov 201745458
Dec 201782828
Jan 201832329
Feb 201837305
Mar 201846495
Apr 201827277
May 201839401
Jun 201851513
Jul 201841412
Aug 201843438
Sep 201840402
Oct 201838472
Nov 201837373
Dec 201850523
Jan 201954471
Feb 2019161814
Mar 201935357
Apr 201931315
May 2019202014
Jun 201931316
Jul 201920203
Aug 201913133
Sep 2019141412
Oct 201920196
Nov 201959566
Dec 20191811814
Jan 202011117
Feb 2020212010
Mar 202018185
Apr 202027255
May 2020232213
Jun 202019187
Jul 202020207
Aug 202011112
Sep 2020615610
Oct 202055544
Nov 202024248
Dec 202020204
Jan 202113123
Feb 202121218
Mar 202116166
Apr 202111117
May 202124248
Jun 202121215
Jul 202122225
Aug 202126268
Sep 2021323211
Oct 2021191923
Nov 2021151517
Dec 202120194
Jan 202213153
Feb 2022784
Mar 202228267
Apr 202266662
May 2022474713
Jun 202232318
Jul 202223268
Aug 202251528
Sep 2022475114
Oct 202232329
Nov 202219199
Dec 202228278
Jan 202325256
Feb 2023323210
Mar 202321216
Apr 2023111112
May 202312126
Jun 202330296
Jul 2023222210
Aug 202313149
Sep 202313136
Oct 2023992
Nov 202323217
Dec 202313133
Jan 202414143
Feb 202416126
Mar 2024201964
Total31822841986